Patents by Inventor Dai OTAGIRI

Dai OTAGIRI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11752069
    Abstract: A cellular medicine transfer system includes: an adapter for a cellular medicine container including a first flow channel and a second flow channel through each of which a liquid and cells can flow; a cellular medicine container to which the adapter is attached, and in which a cellular medicine to be transferred is stored; an administration medium storage container that communicates with the first flow channel, and in which an administration medium is stored; a collection container for collecting a cellular medicine, that communicates with the second flow channel of the adapter; and a powering device that imparts motive power for transferring the administration medium from the administration medium storage container through the first flow channel to the cellular medicine container, and for transferring the cellular medicine and the administration medium from the cellular medicine container through the second flow channel to the collection container.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: September 12, 2023
    Assignees: HEALIOS K. K., SUMITOMO PHARMA CO., LTD.
    Inventors: Masakazu Inamori, Dai Otagiri
  • Patent number: 11524035
    Abstract: The present invention, in which RPE cells are suspended in a medium pharmaceutically acceptable as an ocular irrigating/washing solution and containing a poloxamer, achieves improvement of the post-thawing survival rate of cryopreserved RPE cells, improvement of the photoreceptor cell protection effect by RPE cell transplanted immediately after thawing, and prevention of loss of RPE cells in various steps from thawing to transplantation.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: December 13, 2022
    Assignees: HEALIOS K.K., SUMITOMO PHARMA CO., LTD.
    Inventors: Dai Otagiri, Tadao Maeda
  • Publication number: 20200352825
    Abstract: A cellular medicine transfer system includes: an adapter for a cellular medicine container including a first flow channel and a second flow channel through each of which a liquid and cells can flow; a cellular medicine container to which the adapter is attached, and in which a cellular medicine to be transferred is stored; an administration medium storage container that communicates with the first flow channel, and in which an administration medium is stored; a collection container for collecting a cellular medicine, that communicates with the second flow channel of the adapter; and a powering device that imparts motive power for transferring the administration medium from the administration medium storage container through the first flow channel to the cellular medicine container, and for transferring the cellular medicine and the administration medium from the cellular medicine container through the second flow channel to the collection container.
    Type: Application
    Filed: November 27, 2018
    Publication date: November 12, 2020
    Inventors: Masakazu INAMORI, Dai OTAGIRI
  • Publication number: 20200009196
    Abstract: The present invention, in which RPE cells are suspended in a medium pharmaceutically acceptable as an ocular irrigating/washing solution and containing a poloxamer, achieves improvement of the post-thawing survival rate of cryopreserved RPE cells, improvement of the photoreceptor cell protection effect by RPE cell transplanted immediately after thawing, and prevention of loss of RPE cells in various steps from thawing to transplantation.
    Type: Application
    Filed: June 29, 2017
    Publication date: January 9, 2020
    Applicants: HEALIOS K.K., SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Dai OTAGIRI, Tadao MAEDA